Get the Stockscreener App
16.56
1.13%
-0.19
Wave Life Sciences Ltd stock is traded at $16.56, with a volume of 8.07M.
It is down -1.13% in the last 24 hours and up +138.10% over the past month.
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
See More
Previous Close:
$16.75
Open:
$17.38
24h Volume:
8.07M
Relative Volume:
1.39
Market Cap:
$2.77B
Revenue:
$93.95M
Net Income/Loss:
$-129.87M
P/E Ratio:
-18.40
EPS:
-0.9
Net Cash Flow:
$-202.88M
1W Performance:
+121.09%
1M Performance:
+138.10%
6M Performance:
+130.00%
1Y Performance:
+19.57%
1-Day Range:
$15.86
$17.77
1-Week Range:
$12.72
$21.73
52-Week Range:
$5.28
$21.73
Wave Life Sciences Ltd Stock (WVE) Company Profile
Name
Wave Life Sciences Ltd
Sector
Industry
Phone
617-949-2900
Address
7 STRAITS VIEW, SINGAPORE
Compare WVE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WVE
Wave Life Sciences Ltd
|
16.56 | 2.80B | 93.95M | -129.87M | -202.88M | -0.90 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Oct-20-25 | Initiated | Wells Fargo | Overweight |
| Aug-04-25 | Initiated | Canaccord Genuity | Buy |
| Jul-28-25 | Initiated | Oppenheimer | Outperform |
| Jul-16-25 | Initiated | Citigroup | Buy |
| Jun-11-25 | Resumed | Raymond James | Outperform |
| Apr-29-25 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-08-25 | Initiated | Wedbush | Outperform |
| Feb-25-25 | Initiated | Jefferies | Buy |
| Oct-16-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-27-24 | Resumed | JP Morgan | Overweight |
| Sep-19-24 | Initiated | B. Riley Securities | Buy |
| Sep-09-24 | Initiated | JP Morgan | Overweight |
| May-15-24 | Initiated | Wells Fargo | Overweight |
| Dec-19-23 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Jul-05-23 | Initiated | Raymond James | Outperform |
| May-24-23 | Downgrade | Jefferies | Buy → Hold |
| Dec-15-20 | Resumed | H.C. Wainwright | Buy |
| Oct-23-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-31-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Nov-01-19 | Initiated | Guggenheim | Buy |
| Jul-15-19 | Initiated | Cowen | Market Perform |
| Apr-17-19 | Reiterated | H.C. Wainwright | Buy |
| Aug-07-18 | Initiated | Stifel | Buy |
| Jul-23-18 | Initiated | H.C. Wainwright | Buy |
| Mar-19-18 | Reiterated | Mizuho | Buy |
| Feb-15-17 | Initiated | H.C. Wainwright | Buy |
| Nov-10-16 | Resumed | Leerink Partners | Outperform |
| Dec-07-15 | Initiated | JMP Securities | Mkt Outperform |
| Dec-07-15 | Initiated | Jefferies | Buy |
| Dec-07-15 | Initiated | Leerink Partners | Outperform |
| Dec-07-15 | Initiated | Sun Trust Rbsn Humphrey | Buy |
View All
Wave Life Sciences Ltd Stock (WVE) Latest News
WVE: B. Riley Securities Raises Price Target Amid Positive Outlo - GuruFocus
Wave Life Sciences' Robust 2026 Pipeline to Support Outlook, Wedbush Says - marketscreener.com
B. Riley Adjusts Price Target on Wave Life Sciences to $37 From $19, Maintains Buy Rating - marketscreener.com
WVE Stock Receives Analyst Rating Update from Wedbush | WVE Stoc - GuruFocus
Wedbush raises WAVE Life Sciences stock price target to $33 on obesity data - Investing.com India
Wave Life Sciences (WVE) Sees Price Target Boost to $33 by Wedbu - GuruFocus
Wedbush Raises Price Target on Wave Life Sciences to $33 From $20, Adds to Best Ideas List, Keeps Outperform Rating - marketscreener.com
Jefferies reiterates buy rating on WAVE Life Sciences stock amid recent pressure - Investing.com India
Adrian Rawcliffe Sells 42,000 Shares of WAVE Life Sciences (NASDAQ:WVE) Stock - MarketBeat
Wave Life Sciences (WVE) Stock on December 11, 2025: Obesity Breakthrough, 180% Rally, $350M Offering and Fresh Analyst Targets - ts2.tech
Wave Life Sciences prices upsized $350M stock offering - MSN
Wave Life Science prices upsized $350M stock ofeering - MSN
Wave Life Sciences (WVE) Stock Faces Sharp Decline - GuruFocus
Wave Life Sciences (WVE) Stock Experiences Decline - GuruFocus
WVE Shares Dip After Secondary Offering and Market Reaction - timothysykes.com
WVE Stock Surges More Than 180% in a Week: What Is Driving This Rally? - Nasdaq
Wave Life Sciences director Henry sells shares for $1.36 million By Investing.com - Investing.com Canada
Wave Life Sciences (WVE) soars to 6-year high on obesity drug clinical trial - MSN
Corrigan sells Wave Life Sciences (WVE) shares worth $217k By Investing.com - Investing.com Nigeria
Golden Cross Alert: 3 Stocks With Major Upside Potential - Investing.com
Wave Life Sciences (WVE) CFO Moran sells shares worth $4.1 million By Investing.com - Investing.com Canada
Corrigan sells Wave Life Sciences (WVE) shares worth $217k - Investing.com
Tan Aik Na of Wave Life Sciences sells $1.82 million in stock - Investing.com Nigeria
Wave Life Sciences (WVE) CFO Moran sells shares worth $4.1 million - Investing.com India
Wave Life Sciences exec Francis sells $6.4m in shares - Investing.com India
Verdine of Wave Life Sciences sells shares worth $269k - Investing.com India
Wave Life Sciences director Wagner sells $189,000 in shares - Investing.com India
Wave Life Sciences exec Francis sells $6.4m in shares By Investing.com - Investing.com Nigeria
Verdine of Wave Life Sciences sells shares worth $269k By Investing.com - Investing.com UK
Wave Life Sciences director Henry sells shares for $1.36 million - Investing.com India
Wave Life Sciences director Rawcliffe sells $630k in shares - Investing.com
Insider Sell: Mark Corrigan Sells Shares of WAVE Life Sciences L - GuruFocus
Golden Cross Alert: 3 Stocks With Major Upside Potential - MarketBeat
Is It Too Late To Buy WVE Shares? - timothysykes.com
Wave Life Sciences (WVE) Stock Drops Significantly by 9.7% - GuruFocus
Wave Life Sciences stock falls after announcing $350 million public offering - Investing.com
Wave Life Sciences: 200% Rally On 1% Weight Loss Feels Bloated (NASDAQ:WVE) - Seeking Alpha
Wave Life Sciences (WVE) Upsizes Public Offering to Raise $350 M - GuruFocus
Wave Life Sciences (WVE) Announces Upsized $350M Public Offering - GuruFocus
Wave Life Sciences falls after pricing $350 mln stock offering - TradingView
Why Wave Life Sciences Stock Crushed it Again Today - sharewise.com
Wave Life Sciences Prices Upsized $350 Million Public Offering - marketscreener.com
Wave Life Sciences prices public offering at $19 per share By Investing.com - Investing.com Nigeria
WVE Stock Offering Expanded and Priced Under Market Value - GuruFocus
Wave Life Sciences prices public offering at $19 per share - Investing.com
Wave Life Sciences Prices $350 Million Public Offering of Ordinary Shares and Pre-Funded Warrants - Quiver Quantitative
Wave Life Sciences (Nasdaq: WVE) prices $350M share and pre-funded warrant sale - Stock Titan
Wave Life Sciences prices upsized $350 million offering at a price of $19 per share - marketscreener.com
Wave Life Sciences Prices Upsized $350 Million Public Offering of Ordinary Shares and Pre-Funded Warrants - The Manila Times
Wave Life Sciences Prices Upsized $350 Million Offering At A Price of $19 Per Share - TradingView
Citigroup Maintains Wave Life Sciences (WVE) Buy Recommendation - Nasdaq
Wave Life Sciences Ltd Stock (WVE) Financials Data
Revenue
Net Income
Cash Flow
EPS
Wave Life Sciences Ltd Stock (WVE) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Rawcliffe Adrian | Director |
Dec 08 '25 |
Sale |
15.00 |
42,000 |
630,000 |
12,700 |
| Wagner Heidi L | Director |
Dec 08 '25 |
Option Exercise |
5.97 |
14,000 |
83,580 |
51,930 |
| Wagner Heidi L | Director |
Dec 08 '25 |
Sale |
13.50 |
14,000 |
189,000 |
44,930 |
| HENRY CHRISTIAN O | Director |
Dec 08 '25 |
Option Exercise |
5.07 |
87,000 |
440,790 |
54,700 |
| HENRY CHRISTIAN O | Director |
Dec 08 '25 |
Sale |
14.65 |
93,445 |
1,369,324 |
12,700 |
| Tan Aik Na | Director |
Dec 08 '25 |
Option Exercise |
4.85 |
119,230 |
578,270 |
70,400 |
| Tan Aik Na | Director |
Dec 08 '25 |
Sale |
13.58 |
134,218 |
1,823,158 |
25,400 |
| Verdine Gregory L. | Director |
Dec 08 '25 |
Sale |
13.47 |
20,000 |
269,461 |
275,217 |
| Francis Chris | See Remarks |
Dec 08 '25 |
Option Exercise |
4.78 |
441,031 |
2,107,183 |
147,349 |
| Francis Chris | See Remarks |
Dec 08 '25 |
Sale |
14.57 |
441,031 |
6,427,085 |
25,000 |
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):